Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials

By sjmartinez • July 23, 2024

Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials. JAMA. 2024 Jul 22. doi: 10.1001/jama.2024.12414. Epub ahead of print. PMID: 39037800.

Tags: Digestive Diseases, Publications

A prospective international multisite randomized controlled trial of water exchange with and without distal cap(s) in adenoma detection

Leung FW, Cadoni S, Chen L, Chen Y, Cheng CL, Cheung R, Dixit V, Elashoff D, Friedland S, Gallittu P, Hsieh YH, Cheng CH, Jacob[...]

Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis

Lacy BE, Shin AS, Cangemi DJ, Yang Y, Zhao S, Rosenbaum DP. Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post[...]

Intestinal macrophages modulate synucleinopathy along the gut-brain axis

De Schepper S, Konstantellos V, Conway JA, Sokolova D, Zaccagnini L, Cowley MV, Sierksma A, Yudina M, Edmonds M, Gavriouchkina D, Geary B, Wallis A,[...]